(Q33377159)

English

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit